There were an estimated 490,000 new cases of drug-resistant TB in 2016. Tuberculosis, a lung disease most often transmitted by breathing infected particles in the air, is the ninth leading cause of ...

Tuberculosis is both curable and preventable, yet each year, it still kills more people than any other infectious disease. One reason is that current treatments hinge on rifampicin, an antibiotic that ...

CHICAGO (Reuters) - Drugs used to treat Parkinson's disease show promise as a new way to stem the rise of drug-resistant forms of tuberculosis, U.S. researchers said on Thursday. They said computer ...

(Reuters) - The World Health Organization on Tuesday reported that extensively drug-resistant tuberculosis (XDR-TB), a lethal strain of the contagious lung disease, has spread to 55 countries and ...

A new study uncovers vulnerabilities in drug-resistant TB, offering hope for improved treatments. Rutgers Health research has uncovered why a relatively new antibiotic for tuberculosis (TB) works ...

Tuberculosis (TB), one of the leading infectious disease killers worldwide, has long posed a challenge, particularly with the rise of drug-resistant forms. However, new research offers fresh hope in ...

Despite newer TB drugs, delayed diagnosis, atypical symptoms and drug resistance continue to complicate treatment ...

For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected in at ...

Drug-resistant forms of the bacteria responsible for tuberculosis infections are difficult to identify, hard and expensive to treat, and represent a major global threat to public health. However, ...

LONDON — Drug-resistant tuberculosis is spreading even faster than experts had feared, the World Health Organization warned Tuesday. The rate of TB patients infected with the drug-resistant strain ...

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, ...

A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken once-daily for six months substantially reduced the risk of developing ...